Stephan Lensky

Stephan Lensky has extensive work experience in the pharmaceutical industry. Stephan is currently the President of EpimAb, Inc. in the US, where they also serve as the Chief Business Officer (CBO) and Chief Operating Officer (COO) for EpimAb Biotherapeutics, Inc. In this role, Stephan is responsible for expanding and strengthening their network in the US biotech and investment community. Prior to this, they were the COO/CBO of EpimAb Biotherapeutics, Inc. and the owner of BioteXulting, a consulting agency that provides expertise in deal making, strategy, and general management for biotech companies. Stephan also has a long history with Boehringer Ingelheim, where they held various roles including Corporate Vice President Strategic Transactions and Alliance Management, Senior Regional Business Manager US, and Contract Manager. Stephan started their career at Bayer HealthCare, working as a Licensing Manager and later as the Head of Laboratory. With over 20 years of experience in the pharmaceutical industry, including 15 years in business development, Stephan Lensky has a wealth of knowledge and expertise in the field.

Stephan Lensky's education history is as follows:

From 1992 to 1993, they were a Postdoctoral Fellow at the University of Notre Dame, specializing in Organic Chemistry.

Prior to that, from 1986 to 1992, they pursued their Doctor of Philosophy (PhD) degree in Organic Chemistry at Ludwig-Maximilians-Universität München.

Stephan obtained their Vor-Diplom in Chemistry from Kiel University, where they studied from 1984 to 1986.

Lastly, they completed their secondary education at Kieler Gelehrtenschule, earning their Abitur degree between 1976 and 1984. The field of study for their Abitur is unspecified.